NVO Competitors & Alternatives
Compare Novo Nordisk A/S with similar stocks in the same industry
Drug Manufacturers - General
NVO
Main Stock$43.07
Tradestie Score
38
Market Cap
$262.92B
P/E Ratio
10.9
Revenue Growth
0.0%
Analyst Upside
+9.6%
Top Competitors
20 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
UNH
UNITEDHEALTH GROUP INCORPORATED (Delaware)
|
$379.09
|
$315.45B | 25.2 | 49 | Compare |
|
AZN
AstraZeneca PLC
|
$160.17
|
$261.56B | 23.5 | 52 | Compare |
|
NVS
Novartis AG
|
$137.16
|
$254.99B | 20.7 | 42 | Compare |
|
MRK
Merck & Co., Inc.
|
$143.93
|
$225.13B | 117.7 | 42 | Compare |
|
AMGN
Amgen Inc
|
$377.35
|
$160.70B | 24.3 | 43 | Compare |
|
PFE
Pfizer Inc.
|
$27.72
|
$154.70B | 36.4 | 48 | Compare |
|
GILD
Gilead Sciences Inc
|
$143.72
|
$137.92B | - | 44 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$42.77
|
$121.27B | 22.7 | 39 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$63.64
|
$96.54B | 14.0 | 34 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$48.13
|
$91.59B | 15.1 | 39 | Compare |
More NVO Analysis
Data updated: Sep 13, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
20 stocks in this industry